← Open Payments lookup

QUYNH NGUYEN: Open Payments

NPI 1336676949 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,809 in 73 payments from 31 companies in 2025. Trend: 2023 $597 · 2024 $1,150 · 2025 $1,809

Food & beverage: $1,809
CompanyPaymentsAmount
Janssen Biotech, Inc.8$319
Celgene Corporation7$173
GENZYME CORPORATION5$124
Daiichi Sankyo Inc.3$102
Merck Sharp & Dohme LLC4$99
AstraZeneca Pharmaceuticals LP5$95
Incyte Corporation4$83
Stemline Therapeutics Inc.4$79
Bayer Healthcare Pharmaceuticals Inc.4$77
SOBI, INC3$72

Products named: RYBREVANT, REBLOZYL, AYVAKIT, Enhertu, Orserdu, Nubeqa, KEYTRUDA, Doptelet.

Industry payments across TX — which companies pay providers there.